SPP1 and early-onset autosomal dominant Alzheimer disease: Expression of OPN in the cerebrospinal fluid and brain has been shown to positively correlate with cognitive decline in Alzheimer’s disease patients as well, protecting against the progression of neurodegeneration [19,21,22].